Actelion to host an investor event at American College of Cardiology (ACC.15) Montag, 09. März 2015 - 17:35

Dear member of the investment community

Following the presentation 'Effect of selexipag on morbidity/mortality in pulmonary arterial hypertension: results of the GRIPHON study' by Vallerie V. McLaughlin on March 15, 2015 at 12:00 p.m. PDT, Actelion will host an investor event at American College of Cardiology (ACC.15).

This event is by invitation only for covering buy- and sell-side analysts as well as institutional investors.

If you wish to attend, please contact: investor.relations@actelion.com

Meeting Information

15 March 2015

6.00 - 8.30 p.m. Pacific Daylight Time

Venue

Hard Rock Hotel
207 5th Avenue
San Diego, CA 92101

Highlights

Oral presentation entitled 'Effect of selexipag on morbidity/mortality in pulmonary arterial hypertension: results of the GRIPHON study'.